Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Renal papillary necrosis historical Perspective
Introduction
Overview
Overview
Renal papillary necrosis was first introduced by Friedrich in 1877, following urinary obstruction. Then, other associated factors such as diabetes, sickle cell disease and analgesics were found.
Discovery
Discovery
- Renal papillary necrosis was first discovered by professor Friedrich in 1877, in a patient following urinary obstruction due to prostatic hyperplasia. [1]
- Gunther and Edmonson found association between RPN and diabetes mellitus. [2]
- Analgesic nephropathy was first described by Spuhler and Zollinger in 1953 due to chronic use of pain killer medications containing phenacetin. [3]
- The association between RPN and sickle cell disease was found by Sydenstricker in 1923. [2]
Landmark Events in the Development of Treatment Strategies
Landmark Events in the Development of Treatment Strategies
Impact on Cultural History
Impact on Cultural History
Famous Cases
Famous Cases
References
References
- ↑ Friedreich, N. (1877). “Ueber Necrose der Nierenpapillen bei Hydronephrose”. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 69 (2): 308–312. doi:10.1007/BF02326121. ISSN 0945-6317.
- ↑ 2.0 2.1 Madu AJ, Okoye AE, Ajuba IC, Madu KA, Anigbo C, Agu K (2016). “Prevalence and associations of symptomatic renal papillary necrosis in sickle cell anemia patients in South-Eastern Nigeria”. Niger J Clin Pract. 19 (4): 471–4. doi:10.4103/1119-3077.183299. PMID 27251962.
- ↑ SPUHLER O, ZOLLINGER HU (1953). “[Chronic interstitial nephritis]”. Z Klin Med. 151 (1): 1–50. PMID 13137299.
Editor-In-Chief: Please help WikiDoc by adding content here. It’s easy! Click here to learn about editing.
C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nasrin Nikravangolsefid, MD-MPH [2]